Thursday, October 6, 2011

CLIAWAIVED.com signs distribution deal with Mossman Associates, and licenses global co-marketing rights to Mossman’s rapid nicotine testing technology

CLIAWAIVED.com announced the execution of an agreement for the exclusive US distribution and global co-marketing rights to Mossman’s NicCheck, rapid nicotine testing technology.


San Diego, CA, October 1, 2011

CLIAWAIVED.COM, Inc., the leading internet based, multi-line distributor of POC (point-of- care) CLIA waived Diagnostic tests in the US and Mossman Associates Inc., a leading diagnostic test manufacturer, today announced the execution of an agreement for the exclusive US distribution rights along with global co-marketing rights to Mossman’s NicCheck products and rapid nicotine testing technology.

CLIAwaived.com has agreed to pay Mossman Associates, Inc. an undisclosed fee for exclusive US license rights of NicCheck branded products along with the right to sell Mossman’s rapid nicotine testing products globally under CLIAwaived’s private label brand. Mossman’s NicCheck products are an ideal fit for the CLIAwaived.com portfolio of diagnostic products and will be marketed both in the US and globally with dozens of other rapid diagnostics. Specifically, this addition is strategically aimed at serving the growth-oriented point-of-care diagnostic markets including the increasingly growing need for waived tests in the physician office lab, addiction treatment and clinical research markets. At present, NicCheck is the only FDA Cleared and CLIA waived semi-quantitative instant nicotine test on the market that is CLIA compliant for these market segments.

Donald Mossman, President of Mossman Associates, Inc. said “we are pleased that CLIAWAIVED.COM has opted to become our exclusive distributor in the USA. Their position as the premier site for ordering CLIA waived test kits is a natural fit for our NicCheck product. Their site will offer our existing customers an internet option not currently available to them while exposing our product to a much larger customer base.”

Tim Drapeau, President of CLIAwaived, Inc. said, " I am delighted that Mossman Associates has chosen CLIAwaived.com to sell, distribute and market their NicCheck rapid nicotine testing products exclusively in the US POC market. As a company specializing in distributing CLIA compliant devices we believe the NicCheck product line will dominate our target markets and strengthen our position and portfolio of CLIA waived rapid diagnostics.”

About CLIAWAIVED.COM

CLIAWAIVED.COM, is a leading, Internet based, multi-line distributor of CLIA Waived, point-of-care diagnostic products to the healthcare industry. CLIAWAIVED’s portfolio of distributed products includes rapid diagnostics for early diagnosis and treatment of various diseases and conditions.

About Mossman Associates, Inc.

Mossman Associates, Inc. is a manufacturer and distributor of medical diagnostic test kits whose portfolio of products includes rapid onsite products for detection and screening of drugs of abuse, nicotine and alcohol as well as a serological test for tuberculosis.
Contact: CLIAWAIVED.COM
Mr. Tim Drapeau, President
CLIAwaived,Inc.
11578 Sorrento Valley Road
San Diego, CA 92121
www.cliawaived.com

OR

Mossman Associates, Inc.
Mr. Donald Mossman
9 Village Circle
Milford, MA 01757
www.mossmanassociates.com
508-488-6169

Thursday, June 23, 2011

Smoking Cessation Campaigns Around The World Using NicCheck to Confirm Success Once Again

Milford, Massachusetts; 6/23/2011 - Mossman Associates Inc. is pleased to announce that our NicCheck is being used once again within a number of Smoking Cessation Campaigns around the world.

Campaigns within the Lung Association of Manitoba, Canada as well as campaigns in Taiwan, Montreal, Canada and the University of Minnesota are once again using the NicCheck test to confirm success. This represents consecutive years that the test has been part of these well established campaigns.

Donald Mossman, President of Mossman Associates Inc. notes, "We are pleased to be able to contribute to these programs which are designed to help those people trying to quit smoking. Our NicCheck product has been shown to be effective when used to monitor a person’s nicotine consumption as they reduce their nicotine dependence. Our test is simple and because it is a rapid visual test, it is conducive to being run in the field, lending itself nicely to smoking cessation programs as well as spot checks and remote health locations”.


For more information contact:

Donald Mossman, President
Mossman Associates Inc.
9 Village Circle
Milford, MA 01757
www.nicotinetesting.com
508-488-6169 (P)
don@mossmanassociates.com

Friday, April 1, 2011

NicCheck to be used within evidence based smoking cessation contests, results in time for World No Tobacco Day 2011

May 31, 2011 has been set aside as World No Tobacco Day. The 31st of May each year the World Health Organization (WHO) celebrates World No Tobacco Day, highlighting the health risks associated with tobacco. The WHO uses this day to be an advocate for effective policies to reduce tobacco consumption, specifically through tobacco control messages, and to promote adherence to the WHO Framework Convention on Tobacco Control.

The WHO Framework Convention on Tobacco Control is the world’s foremost tobacco control treaty. This treaty, negotiated under the auspices of the WHO, was put in place in 2005 and to date is the most widely embraced treaty in the history of the United Nations. Currently there are 172 parties endorsing this evidence-based treaty that reaffirms the rights of all people to the highest standard of health and provides new legal dimensions for cooperation in tobacco control.

Once again, Mossman Associates’ NicCheck test has been chosen to be the evidence based test used to confirm smoking cessation in a number of Quit and Win contests around the world. Completion of these and the announcements of the contest winners should be in time to celebrate World No Tobacco Day.

“We can think of no better way to celebrate the upcoming event than to continue our support of these types of contests”, quotes Donald Mossman, President of Mossman Associates. He continues, “Competitions in Finland, Canada, and Taiwan should all conclude in time to celebrate this noteworthy day. We look forward to working with other countries, universities and organizations that take on these types of programs”.

About Mossman Associates, Inc.

Mossman Associates, Inc is a privately held medical device company that specializes in rapid tests for physicians and researchers as well as equipment and reagents for the biotech industry. Incorporated in 2001 the professionals at Mossman Associates Inc have been involved with cutting edge technology for over 30 years.